๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lianyungang
Clinical trial register · China

Clinical Trials in Lianyungang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Lianyungang 5
Narrow the registerReset
Recruitment status
Phase
Site location
Lianyungang5
All 1 locations
Target enrolment
to

Trials with a site in Lianyungang

5 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effect of Peripartum 40 Hz Audiovisual Stimulation on Postpartum Depression in Women Undergoing Elective Cesarean Section: A Randomized Clinical Trial
NCT07807462Depression, Postpartum
The First People's Hospital of Lianyungang
Not applicable
204
Lianyungang
2026-10-01
Not yet open
SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC
NCT07818304Non Small Cell Lung Cancer, Lung Neoplasms
The First People's Hospital of Lianyungang
Phase 2
61
Lianyungang
2026-10
Recruiting
Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia Induction
NCT07323043General Anesthetic Drug Adverse Reaction
The First People's Hospital of Lianyungang
Not applicable
190
Lianyungang
2026-01-15
Recruiting
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
NCT06476093Non-Small-Cell Lung Cancer, Brain Metastases
The First People's Hospital of Lianyungang
Not applicable
46
Lianyungang
2024-07-01
Active, closed
Anesthetic Effect of Ropivacaine on Local Infiltration Anesthesia in Arteriovenous Fistula Surgery
NCT07259772End Stage Renal Disease (ESRD), Arteriovenous Fistula Patency, Chronic Kidney Disease 5D
The First People's Hospital of Lianyungang
Phase 4
40
Lianyungang
2019-04-10
Rows per page Showing 1–5 of 5
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/lianyungang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5 of those studies with a site in Lianyungang that also match the filters currently applied.

How many clinical trials are recruiting in Lianyungang?

2 of the 5 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lianyungang), 5 studies
PhaseStudiesRecruitingShare
Not applicable3260%
Phase 21020%
Phase 41020%

Most active sponsors

Lead sponsors with the most studies (Lianyungang)
Lead sponsorStudiesRecruiting
The First People's Hospital of Lianyungang52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.